Mayo Clinic researchers have developed a digital historical timeline of infectious disease outbreaks and vaccines. The timeline spans the development of a smallpox vaccine in 1796 to the COVID-19 pandemic.
Tracing the genetic evolution of SARS-CoV-2, the virus that causes COVID-19, is crucial for detecting and responding to emerging variants. A team of scientists within Mayo Clinic's COVID-19 Sequencing Command Center is at the forefront of the extensive research and surveillance operation, conducting nearly 750 sequences of the COVID-19 virus each week.
The Minnesota Partnership for Biotechnology and Medical Genomics have announced their 2022 research awardees. This marks the partnership's 18th year of spearheading new scientific ideas from Minnesota to improve the health of, and health care for, Minnesotans.
It has been an impactful year of genomic and multi-omic research and scientific discoveries in Mayo Clinic's Center for Individualized Medicine. While much focus in 2021 was centered on advancing the knowledge of COVID-19, Mayo scientists and physician have also worked to develop individualized treatments, prevention measures and diagnostics for patients with rare and undiagnosed diseases, cancer and other illnesses.
Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity, diabetes, or other conditions associated with metabolic syndrome were at much higher risk of acute respiratory distress syndrome and death, according to an international study published in JAMA Network Open.
Adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients who weren't responding to the treatment, Mayo Clinic research shows. Immunotherapy uses the body’s immune system to prevent, control and eliminate cancer. The study is published in Cancer Immunology Research, a journal of the American Association for Cancer Research.